Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics of [¹⁸F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease.
Snellman A, Rokka J, Lopez-Picon FR, Eskola O, Wilson I, Farrar G, Scheinin M, Solin O, Rinne JO, Haaparanta-Solin M. Snellman A, et al. Among authors: scheinin m. Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1784-95. doi: 10.1007/s00259-012-2178-9. Epub 2012 Jul 17. Eur J Nucl Med Mol Imaging. 2012. PMID: 22801729
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant.
Bergström M, Hargreaves RJ, Burns HD, Goldberg MR, Sciberras D, Reines SA, Petty KJ, Ogren M, Antoni G, Långström B, Eskola O, Scheinin M, Solin O, Majumdar AK, Constanzer ML, Battisti WP, Bradstreet TE, Gargano C, Hietala J. Bergström M, et al. Among authors: scheinin m. Biol Psychiatry. 2004 May 15;55(10):1007-12. doi: 10.1016/j.biopsych.2004.02.007. Biol Psychiatry. 2004. PMID: 15121485 Clinical Trial.
Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.
Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, Oikonen V, Kailajärvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO. Kemppainen NM, et al. Among authors: scheinin m. Neurology. 2006 Nov 14;67(9):1575-80. doi: 10.1212/01.wnl.0000240117.55680.0a. Epub 2006 Sep 13. Neurology. 2006. PMID: 16971697
PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.
Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, Oikonen V, Kailajärvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO. Kemppainen NM, et al. Among authors: scheinin m. Neurology. 2007 May 8;68(19):1603-6. doi: 10.1212/01.wnl.0000260969.94695.56. Neurology. 2007. PMID: 17485647
Assessment of MAO-B occupancy in the brain with PET and [11C]-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301.
Hirvonen J, Kailajärvi M, Haltia T, Koskimies S, Någren K, Virsu P, Oikonen V, Sipilä H, Ruokoniemi P, Virtanen K, Scheinin M, Rinne JO. Hirvonen J, et al. Among authors: scheinin m. Clin Pharmacol Ther. 2009 May;85(5):506-12. doi: 10.1038/clpt.2008.241. Epub 2009 Jan 7. Clin Pharmacol Ther. 2009. PMID: 19129751 Clinical Trial.
389 results